Announcement on Convening the Q3 2025 Performance Briefing
Filed with SSE · · 2 pages · Chinese
Earlier from Guobang Pharma
- Announcement on Completing Term Change of Board of Directors and Appointing Senior Management Members and Securities Affairs Representative
- Notice on Convening the 1st Extraordinary General Meeting in 2025
- Announcement on Completion of Share Transfer of Ownership by Company Shareholders under Shareholder Agreement
- Indicative Announcement on Proposed Share Transfer via Agreement by Company Shareholder to Introduce Strategic Investor and Related Change in Interests
- Announcement on Convening the 2025 Semi-annual Performance Briefing
Later from Guobang Pharma
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on Progress in Implementing Phase II Employee Stock Ownership Plans
- Announcement on the Completion of Non-Trading Transfer and Purchase under the Phase II Employee Stock Ownership Plan
- Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
- Announcement on Progress and Implementation Result of Shares Repurchase and Share Changes
Follow Guobang Pharma into a list and get an email when it puts out news.
Follow Guobang Pharma